Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors

Abstract Oraxol consists of an oral dosage form of the chemotherapeutic agent paclitaxel administered with a novel P‐glycoprotein inhibitor encequidar methanesulfonate monohydrate (formerly named HM30181A), which allows oral treatment of cancers that would otherwise be treated with intravenous pacli...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jimmy He, Christopher G. C. A. Jackson, Sanjeev Deva, Tak Hung, Katriona Clarke, Eva Segelov, Tsu‐Yi Chao, Ming‐Shen Dai, Hsien‐Tang Yeh, Wen Wee Ma, Douglas Kramer, Wing‐Kai Chan, Rudolf Kwan, David Cutler, Jay Zhi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-07-01
coleção:	CPT: Pharmacometrics & Systems Pharmacology
Acesso em linha:	https://doi.org/10.1002/psp4.12799
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!